|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-7-30
|
|
pubmed:abstractText |
To study the proliferation-inhibiting and apoptosis-inducing effects of advanced glycation end products (AGE) modified human serum albumin (AGE-HSA) on human vein endothelial cells.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0376-2491
|
|
pubmed:author |
pubmed-author:ChenXiang-fangXF,
pubmed-author:DongJiao-yunJY,
pubmed-author:KenY HYH,
pubmed-author:LiaoZhen-jiangZJ,
pubmed-author:LinWei-dongWD,
pubmed-author:LiuYing-kaiYK,
pubmed-author:LuShu-liangSL,
pubmed-author:QiaoLiangL,
pubmed-author:QingChunC,
pubmed-author:ShiGui-yingGY,
pubmed-author:ShiJi-xiangJX,
pubmed-author:XiangJunJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
572-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12887747-Apoptosis,
pubmed-meshheading:12887747-Cell Division,
pubmed-meshheading:12887747-Cells, Cultured,
pubmed-meshheading:12887747-Dose-Response Relationship, Drug,
pubmed-meshheading:12887747-Endothelium, Vascular,
pubmed-meshheading:12887747-Glycosylation End Products, Advanced,
pubmed-meshheading:12887747-Humans,
pubmed-meshheading:12887747-Neovascularization, Physiologic,
pubmed-meshheading:12887747-Serum Albumin,
pubmed-meshheading:12887747-Time Factors,
pubmed-meshheading:12887747-Wound Healing
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
[Proliferation-inhibiting effect of advanced glycation end products modified human serum albumin to vascular endothelial cell ECV304].
|
|
pubmed:affiliation |
Shanghai Burn Institute, Burn Department of Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
